logo
The US-China trade escalation has no end in sight. Here's why Beijing's not backing down

The US-China trade escalation has no end in sight. Here's why Beijing's not backing down

Yahoo10-04-2025

What was supposed to be a historic, era-defining trade war launched by US President Donald Trump against a range of countries has, for now, narrowed in on a singular target: China.
On Wednesday, Trump announced a three-month pause on all the 'reciprocal' tariffs that had gone into effect hours earlier – with one exception, deepening a confrontation set to dismantle trade between the world's two largest economies.
The pace of that escalation has been stunning. Over the course of a week, Trump's tariffs on Chinese imports have jumped from 54% to 104% and now 125% – figures that add to existing levies imposed prior to the president's second term. And China has retaliated in kind, raising additional, retaliatory duties on all US imports to 84%.
The showdown sets up an historic rupture that will not only cause pain for both of these deeply intertwined economies – but add tremendous friction to their geopolitical rivalry.
'This is probably the strongest indication we've seen pushing towards a hard decoupling,' said Nick Marro, principal economist for Asia at the Economist Intelligence Unit, referring to an outcome where the two economies have virtually no trade or mutual investment.
'It's really hard to overstate the expected shocks this is going to have, not just to the Chinese economy itself, but also to the entire global trading landscape,' as well as on the US, he said.
Trump appeared to link his decision not to grant China the same reprieve as other nations to Beijing's swift retaliation, telling reporters Wednesday that 'China wants to make a deal, they just don't know how quite to go about it.'
But the view from Beijing looks dramatically different.
Chinese leader Xi Jinping, China's most powerful leader in decades, sees no option for his country to simply capitulate to what it calls America's 'unilateral bullying.' And he's playing to the crowd. Publicly, Beijing has drummed up fervent nationalism around its retaliation – part of a strategy it's been quietly preparing for more than four years since Trump was last in office.
While China has long said it wants to talk, Trump's rapid escalation instead appears to have confirmed for Beijing that the US doesn't. And in Xi's calculation, observers say, China is prepared not just to fight back, but to use Trump's trade turmoil to strengthen its own position.
'Xi has been very clear for a very long time that he expects China will enter a period of protracted struggle with the United States and its allies, that China needed to prepare for that, and they have quite extensively,' said Jacob Gunter, lead economy analyst at Berlin-based think tank MERICS.
'Xi Jinping has accepted that the gauntlet is thrown down, and they are ready to put up a fight.'
Whether Trump would have suspended his so-called retaliatory tariffs on China alongside other nations had Beijing not moved so swiftly to retaliate remains an open question. Canada had retaliated but was included in the reprieve, which does not remove a 10% universal tariff imposed last week.
Regardless, Trump, who the White House described earlier this week as having a 'spine of steel,' and Xi now appear locked in a war of attrition with the potential to upset a lopsided but highly integrated trade relationship worth roughly half a trillion dollars.
For decades, China has been the world's factory floor, where increasingly automated and high-tech production chains churn out everything from household goods and shoes to electronics, raw materials for construction, appliances and solar panels.
Those factories satisfied the demand of American and global consumers for affordable goods but fueled an enormous trade deficit – and a feeling among some Americans, including Trump, that globalization has stolen US manufacturing and jobs.
Trump's ratcheting up of tariffs to well over 125% could now cut China's exports to the US by more than half in the coming years, by some estimates.
Many goods from China won't be able to be quickly replaced – driving up US consumer prices, potentially for years, before new factories come online. That could ring up a tax hike for Americans of roughly $860 billion before substitutions, JP Morgan analysts said Wednesday.
In China, a wide swath of suppliers are likely to see their already narrow margins completely erased, with a new wave of efforts to establish factories in other countries set to begin.
The scale of the tariffs could lead to 'millions of people becoming unemployed' and a 'wave of bankruptcy' across China, according to Victor Shih, director of the University of California San Diego's 21st Century China Center. Meanwhile, US exports to China could 'go close to zero,' he added.
'But China can sustain that (situation) much more so than American politicians can,' he said.
That's, in part, because China's ruling Communist Party leaders do not face swift feedback from voters and opinions polls.
'During Covid they shut down the economy (causing) untold employment, suffering – no problem.'
Beijing too believes it can weather the storm.
'In response to US tariffs, we are prepared and have strategies. We have engaged in a trade war with the US for eight years, accumulating rich experience in these struggles,' a commentary on the front page of Communist Party mouthpiece People's Daily said Monday.
It noted Beijing could take 'extraordinary efforts' to boost domestic consumption, which has been persistently weak, and introduce other policy measures to support its economy. 'The plans to respond are well-prepared and ample,' the commentary said.
And in the face of unknowns about how much further measures could escalate, voices from Beijing appear calm.
'The ultimate outcome hinges on who can withstand a longer 'economic war of attrition,'' economist Cai Tongjuan of China's Renmin University wrote in a state media op-ed earlier this week. 'And China clearly holds a greater advantage in terms of strategic endurance.'
Beijing in recent weeks has also been talking to countries from Europe to Southeast Asia in a bid to expand trade cooperation – and one up the US by winning over American allies and partners exasperated by the on-again-off-again trade war.
But it's been bracing for US trade frictions since Trump's first trade war and his campaign against Chinese tech champion Huawei, which were a wake-up call to Beijing that its economic rise could be derailed if it wasn't prepared.
'The Chinese government have been preparing for this day for six years – they knew this was a possibility,' said Shih in California, who added that Beijing had supported countries to diversify supply chains and looked to manage some of its domestic economic challenges in preparation, among other efforts.
Today, China is much better placed to weather a broader trade conflict, experts say. Compared with 2018, it's expanded its trade relations with the rest of the world, reducing the share of US exports from roughly one-fifth of its total to less than 15%.
Its manufacturers have also set up extensive operations in third countries like Vietnam and Cambodia, in part to take advantage of potentially lower US duties.
China has also built out its supply chains for rare earths and other critical minerals, upgraded its manufacturing technology with AI and humanoid robots and ramped up its advanced technology capabilities, including semiconductors. Since last year, the government has also worked, with varying success, to address issues like weak consumption and high local government debt.
'(China's) weaknesses are significant, but in the context of an all-out brawl, these are manageable. The US is not going to be able to, on its own, bring China's economy to the edge of destruction,' said Scott Kennedy, a senior adviser at the Center for Strategic and International Studies think tank in the US.
'As much as Washington doesn't want to admit it, when China says you can't contain China economically, they have a point.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders
SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders

Business Wire

time31 minutes ago

  • Business Wire

SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders

BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today disclosed that on June 12, 2025, Advantech/Prime Success filed a Petition for Emergency Injunctive Relief against SINOVAC, et al., naming as relief parties Cede & Co., The Depository Trust Company, and Equiniti (the dividend paying agent retained by the SINOVAC Board), which may prevent the SINOVAC Board from paying the US$55.00 special dividend as scheduled on or about July 9, 2025. We learned that Vivo Capital's counsel informed the paying agent that Vivo would challenge the dividend and asked the paying agent to withdraw from facilitating the distribution of the US$55.00 dividend declared by the SINOVAC Board to all valid shareholders. The SINOVAC Board has an obligation to answer this Petition on behalf of all SINOVAC common shareholders to stand up to the egregious actions of Prime Success. We expect to file our Opposition Brief today at 5:00 p.m. Atlantic Standard Time, followed by a hearing on Wednesday, June 18. We continue to be shocked by the self-serving, unnecessary actions by Advantech and Vivo Capital (together known as the 'Dissenting Investor Group') against SINOVAC, threatening the rightful dividend payment to all valid SINOVAC common shareholders. These incomprehensible actions are unacceptable to the SINOVAC Board because: The Dissenting Investor Group has already pocketed more than US$1.1 billion in dividends from SINOVAC's operating subsidiary, while all SINOVAC's valid shareholders received nothing. An amount equal to the aggregate amount of cash that would be payable under the US$55.00 per common share special dividend in respect of the 2018 PIPE shares has been set aside by the SINOVAC Board in an escrow account managed by an independent third party pending final resolution of the legal proceedings, which the Dissenting Investor Group initiated. Thus, there is no risk whatsoever that the Dissenting Investor Group's allocations of the dividend will not be paid if the courts ultimately decide in their favor regarding the PIPE shares. These new actions by the Dissenting Investor Group go against their assertions of their support of the US$55.00 dividend payment in their letters to shareholders and raises the question – how can you trust anything they say in their letters or press releases? The SINOVAC Board will continue to fight these frivolous lawsuits, all of which aim to accomplish one thing: to allow the Dissenting Investor group to double dip on dividends. We feel certain we will prevail quickly in this and other proceedings. The SINOVAC Board is on a mission to restore fairness and deliver value to ALL SINOVAC shareholders. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions. Such statements are based upon current expectations and relate to events that involve known or unknown risks, uncertainties and other factors, including without limitation risks, uncertainties and factors related to the timing of filings, hearings and other litigation-related matters, all of which are difficult to predict and many of which are beyond the Company's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

Taiwan blacklists China's Huawei and SMIC, further aligning with U.S. trade policy
Taiwan blacklists China's Huawei and SMIC, further aligning with U.S. trade policy

CNBC

time31 minutes ago

  • CNBC

Taiwan blacklists China's Huawei and SMIC, further aligning with U.S. trade policy

Taiwan has added China's Huawei and SMIC to its trade blacklist in a move that further aligns it with U.S. trade policy and comes amid growing tensions with Beijing. The International Trade Administration of Taiwan added Huawei and SMIC to its "Strategic High-Tech Commodities Entity List," including a host of their subsidiaries. Taiwan's current regulations require licenses from regulators before domestic firms can ship products to parties named on the entity list. Huawei and SMIC, two of China's leading semiconductor companies, are also on a trade blacklist in the United States and have been impacted by Washington's sweeping controls on advanced chips. Companies such as contract chipmaker Taiwan Semiconductor Manufacturing Co already follow U.S. export restrictions. However, the addition of Huawei and SMIC to the Taiwan blacklist is likely aimed at the reinforcement of this policy and a tightening of existing loopholes, Ray Wang, an independent semiconductor and tech analyst, told CNBC. He added that the new domestic export controls could also raise the punishment for any potential breaches in the future. TSMC had been embroiled in controversy in October last year when semiconductor research firm TechInsights found a TSMC-made chip in a Huawei AI training card. Following the discovery, the U.S. Commerce Department ordered TSMC to halt Chinese clients' access to chips used for AI services, according to a report from Reuters. TSMC could also reportedly face a $1 billion as penalty to settle a U.S. investigation into the matter. Huawei has been working to create viable alternatives to Nvidia's general processing units used for AI. However, experts say the company's advancement has been limited by export controls and a lack of scale and advancement in the domestic chip ecosystem. Still, Huawei had been able to acquire several million GPU dies from TSMC for its Ascend chip design by using previous loopholes before they were discovered, according to Paul Triolo, partner and senior vice president for China at advisory firm DGA-Albright Stonebridge Group. A die refers to a small piece of silicon material that serves as the foundation for building processors and contains the intricate circuitry and components necessary to perform computations. The Taiwanese government's crackdown on exports to SMIC and Huawei also comes amid tense geopolitical tensions with Mainland China, which regards the democratically governed island as its own territory to be reunited by force, if necessary. In April, the U.S. reaffirmed its commitment to support the existing status quo as China conducted large-scale military exercises off the coast of the island. In statements reported by state media on Sunday, China's top political adviser Wang Huning echoed Beijing's position, calling for the promotion of national reunification with Taiwan and for resolute opposition to Taiwan independence.

Morning Bid: Markets in wait-and-see mode on Mideast
Morning Bid: Markets in wait-and-see mode on Mideast

Yahoo

time36 minutes ago

  • Yahoo

Morning Bid: Markets in wait-and-see mode on Mideast

A look at the day ahead in European and global markets from Wayne Cole. While Israel and Iran continue to exchange missiles, markets have been resilient so far on Monday with most Asian indexes in the black. Chinese retail sales topped forecasts, but to no discernible reaction. Oil jumped 4% at the open, but soon calmed down and is now up around 1%. Given the region's history, war in the Middle East is not surprising and, so far, this one does not look like spreading wider. Crucially, investors seem to be assuming Iran will not threaten to close the Strait of Hormuz since that would risk dragging the United States into the conflict. There's also plenty of scope for Saudi Arabia and the rest of OPEC to expand supply if needed to keep prices restrained. The escalation is certainly an unwanted headache for the G7 meeting in Canada, which faces more than enough confrontation ahead over President Trump's tariffs on allies. There has been little sign of concrete progress on any trade deals, and even last week's U.S.-China tariff truce might not have fixed the restrictions on minerals most closely tied to national security. The spike in oil will be an added complication for the Federal Reserve meeting this week, but it would have to be a sustained rise in prices to be a true inflationary threat. A steady outcome on rates is considered a done deal with the real focus on whether the Fed's dot plots keep two cuts for this year, or scale back to just one as some suspect. It's a busy week for central banks in general, with the Bank of Japan expected to stand pat on Tuesday but maybe signal a slowdown in its bond tapering for next year. The Bank of England and Norges Bank are also seen holding steady, while the Riksbank is likely to cut. Markets are fully priced for a quarter point easing to zero from the Swiss National Bank, with a good chance of going negative given the strength of the franc. Key developments that could influence markets on Monday: - Appearances by ECB members Joachim Nagel and Piero Cipollone

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store